Regorafenib and Cetuximab in Patients With Advanced Malignancy
Clinical trial NCT02095054 · COMPLETED
Trial details
- NCT number
- NCT02095054
- Sponsor
- M.D. Anderson Cancer Center
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-03-19
- Primary completion
- 2020-03-27
- Enrollment
- 39
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.